| Molecular formula | C46H65N13O11S2 |
|---|
| Molecular weight | 1040.2 g/mol |
|---|
| Registered trials | 2 |
|---|
| PubChem CID | 14257662 |
|---|
What felypressin is
Felypressin is a synthetic peptide compound with no approved drug label in the United States. It is registered in chemical databases under PubChem CID 14257662, with a molecular formula of C46H65N13O11S2. Because no label exists, this page does not describe approved uses, dosing, or established clinical benefits.
Trial footprint
Public trial registries list 2 registered studies referencing felypressin. Two trials appear in available records: a completed study comparing articaine and prilocaine for maxillary tooth extraction, and a completed study evaluating liposomal prilocaine in maxillary infiltration anesthesia. Both listed trials center on comparator anesthetic agents rather than felypressin itself, so they should not be read as direct efficacy evidence for the compound.
FAQ
No. Felypressin does not have an approved drug label in the United States. It is classified as an unapproved research compound.
There is no approved use to describe, since no FDA label exists for felypressin. Available public data is limited to chemical identity and a small number of registered clinical trials.
Public registries list 2 trials referencing felypressin. Both are completed studies, though they primarily evaluate other anesthetic agents rather than felypressin directly.
Felypressin is cataloged in PubChem under CID 14257662, with a molecular formula of C46H65N13O11S2 and a molecular weight of approximately 1040.2.
No adverse event report data is currently available for felypressin in the sources reviewed, so no side effect summary can be provided.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem ClinicalTrials.gov
Updated 2026-09-19